APA (7th ed.) Citation

G, V., T, R., H, H., H, P., N, S., J, P., . . . F, C. (2017). Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study. Haematologica, 102(5), 895. https://doi.org/10.3324/haematol.2016.152496

Chicago Style (17th ed.) Citation

G, Verhoef, et al. "Association Between Quality of Response and Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Receiving VR-CAP Versus R-CHOP in the Phase 3 LYM-3002 Study." Haematologica 102, no. 5 (2017): 895. https://doi.org/10.3324/haematol.2016.152496.

MLA (9th ed.) Citation

G, Verhoef, et al. "Association Between Quality of Response and Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Receiving VR-CAP Versus R-CHOP in the Phase 3 LYM-3002 Study." Haematologica, vol. 102, no. 5, 2017, p. 895, https://doi.org/10.3324/haematol.2016.152496.